TrialJournal of geriatric oncology2023

The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patients.

Efrat Dotan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.